Olympus Co. (OTCMKTS:OLYMY) Short Interest Down 39.6% in May

Olympus Co. (OTCMKTS:OLYMY) was the recipient of a significant decrease in short interest during the month of May. As of May 29th, there was short interest totaling 39,080 shares, a decrease of 39.6% from the May 14th total of 64,672 shares. Based on an average trading volume of 185,604 shares, the days-to-cover ratio is currently 0.2 days.

Wall Street Analyst Weigh In

Separately, The Goldman Sachs Group downgraded shares of Olympus from a “buy” rating to a “neutral” rating in a report on Monday. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold”.

Olympus Price Performance

OLYMY stock traded down $0.25 during trading on Monday, hitting $10.43. 63,542 shares of the company’s stock traded hands, compared to its average volume of 114,221. Olympus has a 52 week low of $8.08 and a 52 week high of $13.73. The business has a fifty day simple moving average of $10.58 and a 200 day simple moving average of $11.11.

Olympus Company Profile

Olympus Corporation is a Tokyo-based manufacturer specializing in precision technology for the medical, scientific and industrial markets. Established in 1919, the company has built an international reputation for optical and digital imaging solutions that encompass endoscopic systems, microscopes, cameras and related accessories. Olympus leverages its expertise in optics, mechanics and electronics to develop instruments designed to advance diagnostics and scientific discovery.

In the healthcare sector, Olympus is best known for its endoscopy products and therapeutic solutions that support minimally invasive procedures in gastroenterology, pulmonology and urology.